Related Experiment Video

Updated: May 27, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Cutaneous involvement with B-lineage acute lymphoblastic leukemia

Chadi Nabhan, Angelica Tolentino, Andrew Meyer

    Leukemia & Lymphoma
    |November 10, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
    10:52

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

    Published on: March 30, 2018

    Related Experiment Videos

    Last Updated: May 27, 2026

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
    10:52

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

    Published on: March 30, 2018

    Related Concept Videos

    Lineage Commitment01:21

    Lineage Commitment

    Commitment is the  process whereby stem cells:
    Primary Lymphoid Organs01:16

    Primary Lymphoid Organs

    Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
    The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Race, Ethnicity, and Insurance Type on In-hospital Mortality in Children with Traumatic Injury.

    Journal of racial and ethnic health disparities·2026

    Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia.

    Frontiers in oncology·2026

    Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy.

    NPJ precision oncology·2026

    Cancer Drugs and United States Tariffs: Attention Must Be Paid.

    Cancer journal (Sudbury, Mass.)·2025

    Mitigating the Impact of Drug Shortages in Oncology: Lessons Learned From the 2023 Shortages of Carboplatin and Cisplatin.

    Cancer journal (Sudbury, Mass.)·2025

    A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.

    Blood advances·2025

    Treatment inequity among older adults with newly diagnosed acute myeloid leukemia ineligible for intensive therapy.

    Leukemia & lymphoma·2026

    Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison.

    Leukemia & lymphoma·2026

    Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

    Leukemia & lymphoma·2026

    Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

    Leukemia & lymphoma·2026

    Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

    Leukemia & lymphoma·2026

    Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

    Leukemia & lymphoma·2026

    Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

    Case reports in dermatological medicine·2026

    Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.

    Frontiers in endocrinology·2026

    Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.

    Kidney diseases (Basel, Switzerland)·2026

    Diffuse Large B-cell Lymphoma Initially Managed As Secondary Immune Thrombocytopenia: A Case Report.

    Cureus·2026

    Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus.

    Frontiers in lupus·2026

    Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.

    Frontiers in cell and developmental biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us